TABLE 1.
Demographic and Clinical Characteristics of Participants
| Variable | All Groups (269) | A: HIV−/AM− (67) | B: HIV−/AM+ (28) | C: HIV+/AM− (112) | D: HIV+/AM+ (62) | Significant Differences* |
|---|---|---|---|---|---|---|
|
| ||||||
| Gender (male)1 | 101 (38%) | 22 (33%) | 10 (36%) | 46 (41%) | 23 (37%) | |
| Age (years)2 | 32.7 (7.6) | 29.3 (6.5) | 30.6 (7.1) | 34.3 (7.6) | 34.3 (7.6) | A, B < C, D |
| Education (years)2 | 12.9 (3.0) | 14.1 (2.0) | 13.9 (2.4) | 12.3 (3.3) | 12.3 (3.2) | A, B > C, D |
| Beck Depression Index2 | 6.5 (6.6) | 4.7 (4.7) | 5.9 (6.3) | 6.3 (6.8) | 8.9 (7.6) | A, C < D |
| Depressed (n, %)1,4 | 28 (10%) | 1 (1%) | 2 (7%) | 13 (12%) | 12 (19%) | A < D |
| Current CD4+ T (cells/μL)3 | 458 (269–706) | 749 (569–870) | 804 (653–903) | 358 (234–518) | 297 (190–419) | A, B > C > D |
| CD4+ T ≤200 (cells/μL)1 | 35 (13%) | 0 (0%) | 0 (0%) | 18 (16%) | 17 (28%) | A, B < C, D |
| HIV RNA viral load (log10 copies/mL)3 | 4.6 (3.9–5.1) | — | — | 4.5 (3.8–5.0) | 4.7 (4.1–5.2) | |
| HIV RNA >501 | 141/151 (93%) | — | — | 89/95 (94%) | 52/56 (93%) | |
| Hemoglobin (g/dL)3 | 12.4 (11.6–13.5) | 12.8 (12.3–13.7) | 12.4 (11.8–13.6) | 12.1 (11.2–13.5) | 12.1 (11.1–13.5) | A > C, D |
| Global Deficit Score2 | 0.31 (0.30) | 0.24 (0.23) | 0.22 (0.27) | 0.33 (0.29) | 0.39 (0.34) | A, B < D |
| Global Deficit Score ≥ 0.51 | 62 (23%) | 10 (15%) | 4 (14%) | 32 (27%) | 16 (26%) | |
| sCD14 (log10 mg/L)2 | 3.09 (0.15) | 2.99 (0.12) | 3.01 (0.14) | 3.10 (0.14) | 3.16 (0.12) | A < C, D; B < D |
| sCD163 (log10 mg/L)2 | 3.05 (0.32) | 2.91 (0.31) | 2.94 (0.28) | 3.08 (0.32) | 3.13 (0.29) | A < C, D |
1:
count (%)
2:
mean (SD)
3:
median (interquartile range)
4:
depressed if Beck Depression Index >15.
*
Adjusted for multiple comparisons by FDR method.